CytomX Therapeutics (CTMX) Insider Trading & Ownership $0.58 -0.06 (-8.78%) Closing price 04/1/2025 04:00 PM EasternExtended Trading$0.58 +0.00 (+0.17%) As of 04/1/2025 07:56 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Insider Trades Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrendsBuy This Stock CytomX Therapeutics (NASDAQ:CTMX) Insider Buying and Selling ActivityCurrentInsider OwnershipPercentage7.00%Number OfInsiders Buying(Last 12 Months)0Number OfInsiders Selling(Last 12 Months)6Amount OfInsider Selling(Last 12 Months)$72,645.69 Get CTMX Insider Trade Alerts Want to know when executives and insiders are buying or selling CytomX Therapeutics stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily. Email Address CTMX Insider Buying and Selling by Quarter Remove Ads CytomX Therapeutics Insider and Congressional Trades History Insiders and Members of Congress Insiders Only Members of Congress Only Transaction Type Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year 2 Years 3 Years Time Frame * Start Date * End Date Export to Excel Transaction DateNameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails3/18/2025Christopher OgdenCFOSell8,551$0.60$5,130.60 3/18/2025Lloyd A RowlandGeneral CounselSell10,203$0.60$6,121.80 3/18/2025Marcia BelvinSVPSell19,512$0.60$11,707.20 3/18/2025Sean A MccarthyCEOSell37,656$0.60$22,593.60 3/18/2025Yu-Waye ChuInsiderSell4,025$0.60$2,415.00 8/20/2024Christopher OgdenCFOSell1,984$1.23$2,440.32 8/20/2024Jeffrey B LandauInsiderSell4,181$1.23$5,142.63 8/20/2024Sean A MccarthyCEOSell13,898$1.23$17,094.54 (Data available from 1/1/2013 forward) CTMX Insider Trading Activity - Frequently Asked Questions Who is on CytomX Therapeutics's Insider Roster? The list of insiders at CytomX Therapeutics includes Amy C Peterson, Carlos Campoy, Christopher Ogden, Elaine V Jones, Jeffrey B Landau, Lloyd A Rowland, Marcia Belvin, Sean A Mccarthy, and Yu-Waye Chu. Learn more on insiders at CTMX. What percentage of CytomX Therapeutics stock is owned by insiders? 7.00% of CytomX Therapeutics stock is owned by insiders. Learn more on CTMX's insider holdings. Which CytomX Therapeutics insiders have been selling company stock? The following insiders have sold CTMX shares in the last 24 months: Christopher Ogden ($13,780.31), Jeffrey B Landau ($18,857.21), Lloyd A Rowland ($24,263.72), Marcia Belvin ($22,688.16), Sean A Mccarthy ($119,635.89), and Yu-Waye Chu ($2,415.00). How much insider selling is happening at CytomX Therapeutics? Insiders have sold a total of 176,868 CytomX Therapeutics shares in the last 24 months for a total of $201,640.29 sold. CytomX Therapeutics Key ExecutivesDr. Sean A. McCarthy DPHIL (Age 57)Chairman & CEO Compensation: $1.03M More Insider Trading Tools from MarketBeat Related Companies Inhibrx Insider Buying DiaMedica Therapeutics Insider Buying biote Insider Buying Neurogene Insider Buying Protalix BioTherapeutics Insider Buying RAPT Therapeutics Insider Buying Checkpoint Therapeutics Insider Buying LifeVantage Insider Buying Neumora Therapeutics Insider Buying CARGO Therapeutics Insider Buying Insider Tracking Tools CEO Purchases/Sales CFO Purchases/Sales Top Insider Buying Stocks Top Insider Selling Stocks Insider Trades Screener Insider Trades Newsletter Congressional Stock Trades Insider Trading By Country U.S. Insider Trading Activity Canadian Insider Trading Activity U.K. Insider Trading Activity Australia Insider Trading Activity Latest Articles Casey’s General Stores Insider Buys Shares of This Must-Own StockNVIDIA Insiders Sell: This Is What It Means for the Market Top 3 Insider Stock Buys in March—Are They Still Good in April?Grocery Outlet Insider and Institutional Buyers Signal BottomSentinelOne Insider Selling? Why Investors Should Stay Bullish This page (NASDAQ:CTMX) was last updated on 4/2/2025 by MarketBeat.com Staff From Our PartnersTrump Allies Confirm Exec Order 14024 Triggers Dollar CollapseExecutive Order 14024 is paving the way for irreversible damage to the dollar's value—threatening your wealth,...Priority Gold | SponsoredDOGE Social Security bombshell?Elon Musk just dropped another bombshell... He revealed his DOGE organization has been taking aim at Social...Altimetry | Sponsored“Amazon Coin” set to outperform BitcoinChris Rowe – the man who recommended Amazon in 1998… Bitcoin and Ethereum in 2017… And has spotted 44 diffe...True Market Insiders | Sponsored10X Bigger than AI, quantum, EVs, crypto, and robotics combined?World Economic Forum: "Arguably the Most Exciting Human Discovery Since Fire" Sam Altman, Bill Gates, and M...Stansberry Research | SponsoredNew “Trump” currency proposed in DCAfter a massive run-up – tech stocks are crashing. And as you’d suspect, the rich and powerful got out firs...Paradigm Press | SponsoredPartner with Elon Musk on Project Colossus… Before May 1stEven though xAI is a private company, tech legend and angel investor Jeff Brown found a way for everyday folks...Brownstone Research | SponsoredTrump’s Final Plan Presidential insider exposes shocking plot to reshape U.S. economy: The 2025 Trump Reset -- Inside Trump’...Porter & Company | SponsoredOil Surge Predicted... But Are You Ready?Do you own oil and gas stocks? Or are you thinking about buying some? But it's NOT oil stocks, futures, or ...The Oxford Club | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding CytomX Therapeutics, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share CytomX Therapeutics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Buy CTMX Stock Free CTMX Stock Alerts